NEW YORK ( TheStreet) -- Conmed Corporation (Nasdaq: CNMD) hit a new 52-week high Friday as it is currently trading at $29.23, above its previous 52-week high of $29.14 with 117,236 shares traded as of 2:46 p.m. ET. Average volume has been 103,400 shares over the past 30 days.

Conmed has a market cap of $789.6 million and is part of the health care sector and health services industry. Shares are up 7.8% year to date as of the close of trading on Thursday.

CONMED Corporation, a medical technology company, provides surgical devices and equipment for minimally invasive procedures and monitoring. The company has a P/E ratio of 25.1, above the average health services industry P/E ratio of 24.9 and above the S&P 500 P/E ratio of 17.7.
  • Practice your CNMD trading strategies and win cash in our stock game.

TheStreet Ratings rates Conmed as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, solid stock price performance, impressive record of earnings per share growth, good cash flow from operations and expanding profit margins. Although the company may harbor some minor weaknesses, we feel they are unlikely to have a significant impact on results. You can view the full Conmed Ratings Report.

See all 52-week high stocks or get investment ideas from our investment research center.

If you liked this article you might like

Voce's Plants Eyes Stockholder Value, Director Battle at Air Methods

Insider Trading Alert - CNMD, GLAD And IPHI Traded By Insiders

Daniel Plants' Voce Fund Returns 5% as Other Activist Investors Struggle

Insider Trading Alert - CNMD, AL And CNBKA Traded By Insiders

6 Medical Device Stocks to Buy If Ted Cruz Is Elected President